Looking for something specific?
Search within Our Comprehensive Services
Cancer Model
Overview
Cancer is a disease that seriously threatens human health. Its pathogenesis and treatment methods have always been the focus of medical research. Suitable animal models can help scientists replicate physiological and pathological conditions similar to those of cancer, to more accurately screen candidate drugs, evaluate drug efficacy, and accelerate the development of new drugs. In addition, it plays an important role in studying tumor evolution, developing new treatment measures, and treating drug resistance. At present, researchers have established zebrafish xenograft models of lung cancer, gastric cancer, and liver cancer cells for anti-tumor drug research. CD BioSciences is committed to providing marine organism model development services for cancer research, helping scientists deeply understand cancer mechanisms, discover potential therapeutic targets, and accelerate the drug development process.
Figure 1. Zebrafish models of cancer. (Hason M, et al., 2019)
Applications of Our Marine Organism Models in Cancer Research
- Cancer Biology Research
- Biomarker Discovery
- Drug Screening
- Drug Mechanism Analysis
- Toxicity Assessment
- Preclinical Research
We provide development services for a variety of marine models, such as zebrafish, to study the growth, division, and metastasis of cancer cells in depth. Our models can reveal the origin and development mechanism of cancer and promote the progress of basic science. In addition, we use gene editing technology to knock out or overexpress specific genes, which can verify the function of these genes in cancer occurrence.
Through advanced genome and transcriptome analysis technologies, we can identify new cancer-related biomarkers. These markers are of great significance for early diagnosis, prognosis, and treatment response evaluation of cancer.
Marine organisms have rich natural product resources, which often have unique chemical structures and biological activities. Our high-throughput screening platform can quickly screen out new compounds with anti-cancer potential and accelerate the drug development process.
Our team offers detailed drug mechanism research services to further explore the mechanism of action of candidate drugs for the treatment of cancer through marine organism models. We help clients understand how drugs work at the cellular and molecular level, providing a scientific basis for optimizing drug design and improving therapeutic efficacy.
In the drug development process, evaluating the toxicity of candidate drugs is a crucial step. We use a variety of marine organism models to conduct preliminary toxicity tests to help screen for compounds with higher safety. Further, we can provide reliable support for drug development by reducing the risks and costs in subsequent studies.
Marine organism models provide a unique system for in vivo and in vitro experiments. We can develop corresponding models for experiments to simulate the development process of cancer in the human body, providing important data support for the efficacy and safety evaluation of candidate drugs.
Reasons to Choose Us
- Strong technical support. Our team consists of experienced marine biologists and bioinformaticians, who can provide all-round guidance to our clients.
- One-stop service platform. We have advanced experimental equipment and a technical platform to ensure the accuracy of experimental data.
- Customization. We will customize different service solutions according to the client's needs and deliver results in a short period.
Related Services
CD BioSciences is committed to the development and construction of marine organism models, providing a platform for scientific researchers by continuously optimizing and improving their applications in cancer research. For more information about our services, please contact us.
Reference
- Hason M, Bartůněk P. (2019). Zebrafish models of cancer—new insights on modeling human cancer in a non-mammalian vertebrate[J]. Genes. 10(11): 935.
Please kindly note that our services can only be used to support research purposes (Not for clinical use).